Rapt Therapeutics, Inc. (RAPT)
58.02
0.00 (0.00%)
USD |
NASDAQ |
Mar 06, 16:00
Rapt Therapeutics Cash from Investing (TTM) : -56.70M for Sept. 30, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Penumbra, Inc. | -404.59M |
| Amicus Therapeutics, Inc. | -46.43M |
| Disc Medicine, Inc. | -394.30M |
| Amylyx Pharmaceuticals, Inc. | 14.04M |
| Johnson & Johnson | -23.59B |